Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04426825 |
|---|---|
| Brief Title: | A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer |
| First Submitted : | June 9, 2020 |
| First Submitted that Met QC Criteria : | June 9, 2020 |
| First Posted : | June 11, 2020 |
| Last Update Submitted that Met QC Criteria : | January 20, 2021 |
| Last Update Posted : | January 22, 2021 |